| RS1180673589 |
CD3D
|
Health Risk |
Pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS1180673603 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1180676335 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1180694694 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1180704409 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1180715983 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1180748005 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1180759765 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1180780309 |
TMIE
|
Health Risk |
Pathogenic |
— |
| RS1180781773 |
PDGFB
|
Health Risk |
Conflicting classifications of pathogenicity |
Basal ganglia calcification, idiopathic |
| RS118079537 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Myopathy |
| RS1180804356 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 16 |
| RS1180813038 |
TSFM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS118083923 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS1180840764 |
NPR2
|
Health Risk |
Pathogenic |
Tall stature-scoliosis-macrodactyly of the great toes syndrome, Acromesomelic dysplasia 1 |
| RS1180861300 |
HIBCH
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS1180874041 |
RBM10
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS118088187 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Hereditary spherocytosis type 3 |
| RS1180888940 |
ADAR
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 6, Cerebral calcification |
| RS1180908312 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS118091316 |
CYP4F22
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 5, CYP4F22-related disorder |
| RS1180926625 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS118092784 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS1180933570 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS1180937573 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS118093942 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1180939705 |
TRIM32
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1180941945 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1180948133 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS118095726 |
IFT27
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, IFT27-related disorder |
| RS1180962073 |
TTI2
|
Health Risk |
Pathogenic |
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome |
| RS118097056 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1180978840 |
TOR1AIP1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS1180979609 |
TRIOBP
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1180980391 |
DNMT3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS1180981385 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1180986183 |
COLQ
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS1180993602 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1180995978 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1180998665 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1181016921 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1181017104 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1181021204 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney complex, type 1 |
| RS1181051479 |
NF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS118106526 |
PFKL
|
Health Risk |
Conflicting classifications of pathogenicity |
PFKL-related disorder, PFKL-related disorder |
| RS1181067492 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS118106981 |
NDUFA10
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS1181074160 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1181083611 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Congenital myopathy 22A |
| RS1181086213 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1181095991 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1181139153 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS1181142850 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1181152684 |
PKP2
|
Health Risk |
Pathogenic |
Sudden unexplained death, Sudden unexplained death |
| RS1181159671 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome and related disorders, Joubert syndrome |
| RS1181161932 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type A |
| RS1181168635 |
PKD1
|
Health Risk |
Likely pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS1181170417 |
TOP3A
|
Health Risk |
Pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5 |
| RS1181178656 |
KIAA1549
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS118121148 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 37 |
| RS1181216326 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1181222222 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1181224255 |
GAD1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Developmental and epileptic encephalopathy 89 |
| RS1181252259 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS118126378 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1181271457 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS118128831 |
STIM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stormorken syndrome, Combined immunodeficiency due to STIM1 deficiency |
| RS1181336139 |
ITGB3
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1181337385 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1181345434 |
USH2A
|
Health Risk |
Pathogenic |
USH2A-related disorder, USH2A-related disorder |
| RS1181350360 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1181351466 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1181354869 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS118136428 |
PDHX
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3-binding protein deficiency, PDHX-related disorder |
| RS1181378221 |
EDAR
|
Health Risk |
Likely pathogenic |
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type |
| RS1181419614 |
SI
|
Health Risk |
Likely pathogenic |
— |
| RS1181434652 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2O |
| RS1181436417 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS1181445340 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1181453325 |
RPGRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 6, Cone-rod dystrophy 13 |
| RS118146260 |
DNAH10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS118147046 |
BRWD1
|
Health Risk |
Conflicting classifications of pathogenicity |
BRWD1-related disorder, BRWD1-related disorder |
| RS1181477970 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS118147866 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS1181487342 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS1181500076 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS1181501831 |
ROBO1
|
Health Risk |
Pathogenic |
Rhabdomyosarcoma, Rhabdomyosarcoma |
| RS1181505507 |
HBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
alpha Thalassemia, Erythrocytosis |
| RS1181511105 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1181528755 |
FKRP
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
| RS1181555052 |
THPO
|
Health Risk |
Likely pathogenic |
Amegakaryocytic thrombocytopenia, congenital |
| RS1181572912 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS118158347 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS1181586555 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1181595292 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1181604094 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS118161093 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1181612302 |
UFC1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with spasticity and poor growth, Neurodevelopmental disorder with spasticity and poor growth |
| RS118161496 |
NUBPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mitochondrial complex I deficiency |
| RS1181626947 |
GLRA1
|
Health Risk |
Likely pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |